X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (49) 49
humans (44) 44
index medicus (43) 43
female (34) 34
male (33) 33
aged (29) 29
middle aged (25) 25
surgery (21) 21
aged, 80 and over (20) 20
retrospective studies (19) 19
treatment outcome (19) 19
visual acuity (19) 19
adult (18) 18
follow-up studies (17) 17
macular degeneration (16) 16
visual acuity - physiology (14) 14
intravitreal injections (13) 13
vascular endothelial growth factor a - antagonists & inhibitors (12) 12
ranibizumab (11) 11
tomography, optical coherence (10) 10
angiogenesis inhibitors - therapeutic use (9) 9
bevacizumab (9) 9
fluorescein angiography (9) 9
prospective studies (9) 9
abridged index medicus (8) 8
drug therapy (8) 8
angiogenesis inhibitors - administration & dosage (7) 7
choroidal neovascularization - drug therapy (7) 7
clinical trials (7) 7
physiological aspects (7) 7
retina (7) 7
vitrectomy (7) 7
macular degeneration - complications (6) 6
patients (6) 6
retinal detachment - surgery (6) 6
wet macular degeneration - drug therapy (6) 6
choroidal neovascularization - etiology (5) 5
endothelial growth-factor (5) 5
eye diseases (5) 5
macular degeneration - drug therapy (5) 5
neovascularization (5) 5
pars-plana vitrectomy (5) 5
postoperative complications (5) 5
retinal perforations - surgery (5) 5
time factors (5) 5
adolescent (4) 4
antibodies, monoclonal, humanized - therapeutic use (4) 4
care and treatment (4) 4
choroidal neovascularization - diagnosis (4) 4
diabetic retinopathy (4) 4
double-blind method (4) 4
fundus oculi (4) 4
injections (4) 4
internal medicine (4) 4
intravitreal ranibizumab (4) 4
retinopathy (4) 4
risk factors (4) 4
safety (4) 4
therapy (4) 4
vascular endothelial growth factor (4) 4
vitrectomy - adverse effects (4) 4
vitreous body (4) 4
angiogenesis inhibitors - adverse effects (3) 3
article (3) 3
blindness (3) 3
blood flow velocity (3) 3
choroidal neovascularization - physiopathology (3) 3
consulting services (3) 3
endotamponade (3) 3
genetic structures (3) 3
hospitals (3) 3
injection (3) 3
intraoperative complications (3) 3
macular edema - drug therapy (3) 3
optical coherence tomography (3) 3
outcomes (3) 3
photochemotherapy (3) 3
photodynamic therapy (3) 3
randomized clinical-trial (3) 3
retinal detachment - physiopathology (3) 3
retinal diseases - surgery (3) 3
retinal hemorrhage - drug therapy (3) 3
retinal perforations - drug therapy (3) 3
retinal perforations - etiology (3) 3
retinitis pigmentosa (3) 3
subfoveal choroidal neovascularization (3) 3
verteporfin (3) 3
vision disorders - etiology (3) 3
visual acuity - drug effects (3) 3
vitrectomy - methods (3) 3
wet macular degeneration - physiopathology (3) 3
7 ingeniería y tecnología (2) 2
age (2) 2
analysis (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal, humanized (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
aptamers, nucleotide - administration & dosage (2) 2
aptamers, nucleotide - therapeutic use (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 10, pp. 2248 - 2254
Journal Article
Ophthalmology, ISSN 0161-6420, 2011, Volume 118, Issue 8, pp. 1694 - 1694
Journal Article
Ophthalmology, ISSN 0161-6420, 2015, Volume 122, Issue 8, pp. 1547 - 1554
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2010, Volume 117, Issue 11, pp. 2134 - 2140
Purpose To evaluate the visual outcome, number of injections, and direct medical cost of a “treat and extend” regimen (TER) in managing neovascular age-related... 
Ophthalmology | Macular degeneration | Physiological aspects | Usage
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2015, Volume 122, Issue 2, pp. 391 - 398.e5
Journal Article